Eribulin Advz 0

Eribulin Mesylate is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping cancer cell growth. Learn more about its uses and effects.

Eribulin Mesylate is primarily used in the treatment of advanced breast cancer and liposarcoma. It is administered intravenously and is often considered when other treatments have not been effective. The drug targets cancer cells to inhibit their growth and spread. Patients and healthcare providers may explore its use in specific cancer types based on individual medical histories.

Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some patients may experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. These effects can vary in severity and duration, depending on the individual and their treatment plan.

Eribulin Mesylate should be handled with care, as it is a potent chemotherapy agent. It is important to follow proper safety protocols when administering the drug to avoid contamination. Patients should be monitored for signs of infection or other complications during treatment. Always consult a healthcare provider for personalized advice.

Eribulin Mesylate may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the drug's efficacy or increase the risk of side effects.